pCR Isn’t the Whole Story: How Oncologists Communicate Risk

Drs. Mouabbi and Birhiray discuss why achieving pCR shouldn’t be seen as a “win or lose” moment in early HER2+ breast cancer. Patients deserve celebration—but also the awareness that residual risk persists, requiring continued management strategies beyond the pCR.